Mohan N. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohan N. Patel has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Bhupesh S. Bhatt
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India
35 shared publications - Pramod B. Pansuriya
School of Chemistry and Physics, University of KwaZulu-Natal, Westville Campus, Durban 4000, South Africa
14 shared publications Khyati P. Thakor
Sardar Patel University
13 shared publicationsMiral V. Lunagariya
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, Gujarat 388 120, India
13 shared publicationsPromise A. Dosi
12 shared publications- Hitesh M. Parekh
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar-388120, Gujarat, India
11 shared publications
Latest Publications
- 16 September 2025
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 92, 127747
Heteroleptic N, N donor carbonitrile based Au(III) complexes: DNA/BSA interaction studies, Molecular Docking, and cytotoxicity studies
- 16 September 2025
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 92, 127747
Heteroleptic N, N donor carbonitrile based Au(III) complexes: DNA/BSA interaction studies, Molecular Docking, and cytotoxicity studies
- 30 May 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (21)
Synthesis, Characterization, and Biological Studies of Organometallic Compounds of Re(I) with 2‐(5‐(4‐Nitrophenyl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)benzo[d]thiazole Based Derivatives
Organometallic Re(I) complexes and substituted 2‐(5‐(4‐nitrophenyl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)benzo[d] thiazole were effectively synthesized and characterized using a variety of spectroscopic techniques. Through viscosity measurements and absorption titration tests, their interaction with CT‐DNA was investigated. An intercalation binding mode was discovered, and molecular docking analysis confirmed this finding. Additionally, protein‐binding affinity was assessed by BSA binding assays. Tests of the synthesized compounds' antibacterial activity against three Gram‐negative and two Gram‐positive strains showed that Re(I) complexes exhibit more potent antibacterial activities than free ligands. SwissADME was used to predict pharmacokinetic parameters. DFT computations were used to calculate the compounds' molecular orbital energies. Furthermore, the anticancer potential was tested against MCF‐7 cells, and cytotoxicity was evaluated using a brine shrimp lethality assay. The compounds with ‐F and ‐OCH 3 groups, complexes C 4 and C 2 , have the lowest IC 50 values (92.48 µg/mL and 98.76 µg/mL, respectively). All complexes are more potent than carboplatin, with an IC 50 value of 165.28 µg/mL, and are closer to cisplatin (80.00 µg/mL). Pyrazole and thiazole moieties in broaden the range of biological activities. Especially in anticancer therapy, where their capacity to interact with many cellular targets might enhance efficacy and decrease resistance, these drugs have demonstrated encouraging outcomes.
- 30 May 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (21)
Synthesis, Characterization, and Biological Studies of Organometallic Compounds of Re(I) with 2‐(5‐(4‐Nitrophenyl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)benzo[d]thiazole Based Derivatives
Organometallic Re(I) complexes and substituted 2‐(5‐(4‐nitrophenyl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)benzo[d] thiazole were effectively synthesized and characterized using a variety of spectroscopic techniques. Through viscosity measurements and absorption titration tests, their interaction with CT‐DNA was investigated. An intercalation binding mode was discovered, and molecular docking analysis confirmed this finding. Additionally, protein‐binding affinity was assessed by BSA binding assays. Tests of the synthesized compounds' antibacterial activity against three Gram‐negative and two Gram‐positive strains showed that Re(I) complexes exhibit more potent antibacterial activities than free ligands. SwissADME was used to predict pharmacokinetic parameters. DFT computations were used to calculate the compounds' molecular orbital energies. Furthermore, the anticancer potential was tested against MCF‐7 cells, and cytotoxicity was evaluated using a brine shrimp lethality assay. The compounds with ‐F and ‐OCH 3 groups, complexes C 4 and C 2 , have the lowest IC 50 values (92.48 µg/mL and 98.76 µg/mL, respectively). All complexes are more potent than carboplatin, with an IC 50 value of 165.28 µg/mL, and are closer to cisplatin (80.00 µg/mL). Pyrazole and thiazole moieties in broaden the range of biological activities. Especially in anticancer therapy, where their capacity to interact with many cellular targets might enhance efficacy and decrease resistance, these drugs have demonstrated encouraging outcomes.
- 16 December 2024
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 115, 108313
Synthesis, characterization, and biological activities of novel organometallic compounds of rhenium(I) with 2-(2-benzylidenehydrazinyl) benzothiazole Schiff-base derivatives: Molecular docking, ADME, and DFT studies
- 16 December 2024
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 115, 108313
Synthesis, characterization, and biological activities of novel organometallic compounds of rhenium(I) with 2-(2-benzylidenehydrazinyl) benzothiazole Schiff-base derivatives: Molecular docking, ADME, and DFT studies
- Open Access
- 20 June 2024
- Published by Slovenian Chemical Society in Acta Chimica Slovenica
- Vol. 71 (2) , 334-352
Synthesis, Characterization and Biological Applications of Substituted Indolo[2,1-b]quinazolin-12(6H)-one Based Rhenium(I) Organometallic Compounds
The Re(I) organometallic compounds [(Re(CO)3L1–6)Cl], where ligands L are tryptanthrin derivatives, prepared and characterized by various spectroscopic techniques. To assess the binding capacities and binding manner, tests of calf thymus DNA under the impact of organometallic complexes were conducted using absorption titration and viscosity measuring techniques. Data from the research mentioned above point to an intercalation type of binding, which was verified by the docking study. Swiss ADME tools were used to carry out an ADME study. The work focuses on computing the molecular orbital energies for the synthesized compounds using the density functional theory (DFT). The compounds were tested against the MCF-7 cell line to determine their anticancer effects. It was observed that their IC50 values were equivalent to those of the standard medication, indicating that they had a similar antiproliferative impact.
- 20 June 2024
- Published by Slovenian Chemical Society in Acta Chimica Slovenica
- Vol. 71 (2) , 334-352
Open AccessSynthesis, Characterization and Biological Applications of Substituted Indolo[2,1-b]quinazolin-12(6H)-one Based Rhenium(I) Organometallic Compounds
The Re(I) organometallic compounds [(Re(CO)3L1–6)Cl], where ligands L are tryptanthrin derivatives, prepared and characterized by various spectroscopic techniques. To assess the binding capacities and binding manner, tests of calf thymus DNA under the impact of organometallic complexes were conducted using absorption titration and viscosity measuring techniques. Data from the research mentioned above point to an intercalation type of binding, which was verified by the docking study. Swiss ADME tools were used to carry out an ADME study. The work focuses on computing the molecular orbital energies for the synthesized compounds using the density functional theory (DFT). The compounds were tested against the MCF-7 cell line to determine their anticancer effects. It was observed that their IC50 values were equivalent to those of the standard medication, indicating that they had a similar antiproliferative impact.
- Open Access
- 15 December 2023
- Published by Elsevier in Results in Chemistry
- Vol. 7
Synthesis, characterization, biomolecular interaction, cytotoxicity, and computational studies of quinoxaline-based platinum(II) complexes
- 15 December 2023
- Published by Elsevier in Results in Chemistry
- Vol. 7
Open AccessSynthesis, characterization, biomolecular interaction, cytotoxicity, and computational studies of quinoxaline-based platinum(II) complexes
- Open Access
- 29 June 2023
- Published by Elsevier in Chemical Physics Impact
- Vol. 7
Molecular modeling, DFT studies, and biological evaluation of pyrazine-based platinum(II) complexes
- 29 June 2023
- Published by Elsevier in Chemical Physics Impact
- Vol. 7
Open AccessMolecular modeling, DFT studies, and biological evaluation of pyrazine-based platinum(II) complexes
- 3 July 2022
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 42 (6) , 2991-3007
Synthesis, Characterization, and Biological Evaluation of Osmium(IV) Pyrazole Carbothioamide Complexes
Osmium(IV) pyrazole carbothioamide complexes with different substituted pyrazole carbothioamide heterocyclic ligands have been synthesized and characterized. The ligands have been characterized using H-1-NMR, C-13-APT, LC-MS, elemental analysis, and IR spectroscopy. Whereas, osmium(IV) compounds have been characterized using ESI-MS, ICP-OES, IR spectroscopy, magnetic, and conductance measurements. The compounds have been evaluated for various biological activities. The binding constant of ligands and complexes have been found in the range of 1.2-3.6 x 10(4) and 1.2-6.8 x 10(4) M-1, respectively. The docking energy values of complexes have been found in the range of -286.28 to -326.49 kJ/mol. The K (sv) and K (f) values of Os(IV) compounds evaluated using fluorescence quenching activity have been found in the range of 4.7-9.2 x 10(3) and 1.3-7.6 x 10(3) M-1, respectively. The minimum inhibitory concentration of osmium(IV) compounds and ligands have been found in the range of 50-75 mu M and 120-135 mu M, respectively. The LC50 values evaluated using brine shrimp lethality assay of osmium(IV) compounds and ligands have been found in a range of 7.52-16.12 mu g/mL and 15.80-20.03 mu g/mL, respectively.
- 3 July 2022
- Published by Taylor & Francis in Polycyclic Aromatic Compounds
- Vol. 42 (6) , 2991-3007
Synthesis, Characterization, and Biological Evaluation of Osmium(IV) Pyrazole Carbothioamide Complexes
Osmium(IV) pyrazole carbothioamide complexes with different substituted pyrazole carbothioamide heterocyclic ligands have been synthesized and characterized. The ligands have been characterized using H-1-NMR, C-13-APT, LC-MS, elemental analysis, and IR spectroscopy. Whereas, osmium(IV) compounds have been characterized using ESI-MS, ICP-OES, IR spectroscopy, magnetic, and conductance measurements. The compounds have been evaluated for various biological activities. The binding constant of ligands and complexes have been found in the range of 1.2-3.6 x 10(4) and 1.2-6.8 x 10(4) M-1, respectively. The docking energy values of complexes have been found in the range of -286.28 to -326.49 kJ/mol. The K (sv) and K (f) values of Os(IV) compounds evaluated using fluorescence quenching activity have been found in the range of 4.7-9.2 x 10(3) and 1.3-7.6 x 10(3) M-1, respectively. The minimum inhibitory concentration of osmium(IV) compounds and ligands have been found in the range of 50-75 mu M and 120-135 mu M, respectively. The LC50 values evaluated using brine shrimp lethality assay of osmium(IV) compounds and ligands have been found in a range of 7.52-16.12 mu g/mL and 15.80-20.03 mu g/mL, respectively.
- Open Access
- 6 May 2022
- Published by Springer Nature in Research Square
Computational And Biological Studies Of Platinum(II) Complex Of Tryptathrin Schiff Base
A series of tryptanthrin alkaloid based ligands (L1-L7) and corresponding platinum(II) complexes were synthesized and characterized by various spectroscopic techniques, LC-MS, magnetic measurement, and electronic spectra. DFT studies were performed for structure optimization. Viscosity measurement, UV-Vis spectroscopy, and molecular docking studies were used to determine the binding mode between CT-DNA and complexes; the intercalation mode of bindings was concluded from the study. The Kb values for compounds-DNA binding were found in the range of 0.42 × 105 – 3.90 × 105 M− 1. The binding study of complexes with BSA was evaluated by fluorescence quenching study, and the value of Ksv, binding constant (Ka), and binding site(n) were in the range of 1.14–2.70 × 103 M− 1, 0.13–0.55 × 105 M− 1, and 0.94–1.16, respectively. Bacteriostatic activity of the synthesized compound was performed against gram + ve and gram -ve bacteria. MIC values of complexes and ligands were found in the range of 35–75 µM and 150–245 µM, respectively. BSLB was performed to check the cytotoxicity of the synthesized compounds. The LC50 values of the ligands and complexes were found in the range of 9.24–11.18 µg/mL and 5.9–7.94 µg/mL, respectively. Anticancer activity against the MG-63 cell line was performed to check potency against the cancer cell line. The IC50 values of the synthesized compounds were found in the range of 10.9 µg/mL 28.7µg/mL. IC50 value of the complex III is 10.9 µg/mL, which is comparable with the standard drug cisplatin.
- 6 May 2022
- Published by Springer Nature in Research Square
Open AccessComputational And Biological Studies Of Platinum(II) Complex Of Tryptathrin Schiff Base
A series of tryptanthrin alkaloid based ligands (L1-L7) and corresponding platinum(II) complexes were synthesized and characterized by various spectroscopic techniques, LC-MS, magnetic measurement, and electronic spectra. DFT studies were performed for structure optimization. Viscosity measurement, UV-Vis spectroscopy, and molecular docking studies were used to determine the binding mode between CT-DNA and complexes; the intercalation mode of bindings was concluded from the study. The Kb values for compounds-DNA binding were found in the range of 0.42 × 105 – 3.90 × 105 M− 1. The binding study of complexes with BSA was evaluated by fluorescence quenching study, and the value of Ksv, binding constant (Ka), and binding site(n) were in the range of 1.14–2.70 × 103 M− 1, 0.13–0.55 × 105 M− 1, and 0.94–1.16, respectively. Bacteriostatic activity of the synthesized compound was performed against gram + ve and gram -ve bacteria. MIC values of complexes and ligands were found in the range of 35–75 µM and 150–245 µM, respectively. BSLB was performed to check the cytotoxicity of the synthesized compounds. The LC50 values of the ligands and complexes were found in the range of 9.24–11.18 µg/mL and 5.9–7.94 µg/mL, respectively. Anticancer activity against the MG-63 cell line was performed to check potency against the cancer cell line. The IC50 values of the synthesized compounds were found in the range of 10.9 µg/mL 28.7µg/mL. IC50 value of the complex III is 10.9 µg/mL, which is comparable with the standard drug cisplatin.